Archive for February, 2021
February 5, 2021
Today, the U.S. Food and Drug Administration authorized marketing of a new prescription only device intended to reduce snoring and mild obstructive sleep apnea. Unlike…
February 5, 2021
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell…
February 5, 2021
The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Feb. 26, 2021, to…
February 4, 2021
As the public health agency responsible for regulating medical products, we must ensure that health care providers have the most up-to-date diagnostics, treatments and vaccines…
Latest Posts
Tags
Animal & Veterinary
Award
Biologics
Coronavirus
Cosmetics
Dietary Supplements
Drugs
Follow @FDAmedia on Twitter
Follow @FDAMedia on X
Follow @US_FDA on Twitter
Follow @US_FDA on X
Follow FDA on Facebook
Food & Beverages
Infant Formula & Foods
Infectious Disease
Medical Devices
Office
Over-the-Counter Drugs
Press Announcements
Tobacco
Training
Vaccines

